# Advocates for Youth

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/advocates-for-youth/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 84 |
| Citations | 20,770 |
| City | Washington D.C. |
| Country | US |
| Description | Advocates for Youth is a research organisation in Washington D.C., US. OpenAlex records 1,401 works and 20,770 citations for it. 511 researchers list it as their most recent affiliation. |
| Homepage | http://www.advocatesforyouth.org/ |
| OpenAlex ID | https://openalex.org/I1306567688 |
| Region | District of Columbia |
| Researchers | 511 |
| ROR ID | https://ror.org/05gy1hc18 |
| Type | nonprofit |
| Wikidata ID | https://www.wikidata.org/wiki/Q4686896 |
| Works | 1,401 |

## University papers

- [Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer](https://scholariq.org/papers/paclitaxel-carboplatin-alone-or-with-bevacizumab-for-non-small-cell-lung-cancer/)
- [Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer](https://scholariq.org/papers/efficacy-of-gefitinib-an-inhibitor-of-the-epidermal-growth-factor-receptor/)
- [Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs](https://scholariq.org/papers/using-multiplexed-assays-of-oncogenic-drivers-in-lung-cancers-to-select-targeted/)
- [Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis](https://scholariq.org/papers/cisplatin-versus-carboplatin-based-chemotherapy-in-first-line-treatment-of/)
- [Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study](https://scholariq.org/papers/gefitinib-versus-placebo-in-completely-resected-non-small-cell-lung-cancer/)

## University top topics

Showing 8 of 14.

- [Palliative Care and End-of-Life Issues](https://scholariq.org/topics/palliative-care-and-end-of-life-issues/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Ethics in Clinical Research](https://scholariq.org/topics/ethics-in-clinical-research/)
- [Migration, Health and Trauma](https://scholariq.org/topics/migration-health-and-trauma/)
- [Cancer survivorship and care](https://scholariq.org/topics/cancer-survivorship-and-care/)
- [Adolescent Sexual and Reproductive Health](https://scholariq.org/topics/adolescent-sexual-and-reproductive-health/)
- [Reproductive Health and Contraception](https://scholariq.org/topics/reproductive-health-and-contraception/)
- [Global trade and economics](https://scholariq.org/topics/global-trade-and-economics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.